5/13/2020 | IG | Fitch ups, withdraws Allergan
|
5/13/2020 | IGLM | AbbVie gets tenders for $13.99 billion, €3.06 billion Allergan notes
|
5/8/2020 | BKIG | S&P upgrades Allergan
|
5/5/2020 | IGLM | AbbVie extends exchange for Allergan notes for expected last time
|
4/27/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more week
|
4/20/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more week
|
4/6/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by two more weeks
|
3/23/2020 | IGLM | Abbvie extends exchange offers for Allergan notes by two more weeks
|
2/24/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by two more weeks
|
1/27/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more month
|
12/31/2019 | IG | Market Commentary: Outlook 2020: High-grade bond supply to decline for third year; merger funding needs drop
|
12/20/2019 | IGLM | AbbVie extends exchange offers for Allergan notes by one more month
|
11/22/2019 | IG | Market Commentary: Light supply eyed for holiday week; Intel, Dominion Energy soft; AbbVie firms; Westpac stable
|
11/18/2019 | IGLM | AbbVie extends exchange offers for Allergan notes to Dec. 31
|
11/18/2019 | IGLM | AbbVie extends exchange offers for Allergan notes to Dec. 31
|
11/12/2019 | IG | Market Commentary: Ford prices split-rated tap; Westpac offers dollar notes; heavy high-grade volume in pipeline
|
11/8/2019 | IG | Market Commentary: JPMorgan prices $750 million tap; heavy volume expected in week ahead; Credit Suisse firms
|
11/7/2019 | IGLM | AbbVie announces early participation results of exchange offer for 18 series of Allergan notes
|
11/7/2019 | IG | Market Commentary: Patterson-UTI prices downsized notes; FHLBank prints; Hasbro considers deal; inflows reported
|
11/6/2019 | IG | Market Commentary: Cheniere, Vistra, Equinix, Healthpeak, Ryder, SEK price; AbbVie markets multiple-tranche deal
|
11/6/2019 | IG | AbbVie launches offering of senior notes to fund Allergan merger
|
10/25/2019 | IGLM | AbbVie launches exchange offer for 18 series of Allergan notes
|
6/28/2019 | BKIG | Fitch might lift Allergan
|
6/26/2019 | IG | Market Commentary: High-grade registered primary market quiets; Telus prices; FS KKR Capital considers bond deal
|
6/26/2019 | IG | Market Commentary: High-grade registered primary market quiets; Telus prices; FS KKR Capital considers bond deal
|
6/26/2019 | IG | Hefty high-grade debt offering eyed for AbbVie, Allergan merger
|
6/25/2019 | BKIG | AbbVie gets $38 billion bridge loan to acquire Allergan, repay debt
|
6/25/2019 | BKIG | S&P puts Allergan on positive watch
|
6/25/2019 | BKIG | Moody’s might up Allergan plc
|
3/18/2019 | IG | Fitch changes Allergan view
|
11/8/2018 | CVIG | Fitch rates Allergan notes BBB-
|
11/8/2018 | CVIG | Moody's rates Allergan notes Baa3
|
11/8/2018 | IG | S&P rates Allergan notes BBB
|
2/7/2018 | IG | S&P changes Allergan to stable
|
5/24/2017 | IGLM | Allergan gives early tally, ups tender cap to $2.8 billion; pricing set
|
5/24/2017 | IGLM | Allergan gives early tender results, lifts offer cap to $2.84 billion
|
5/23/2017 | IG | Fitch rates Allergan notes BBB-
|
5/23/2017 | IG | Moody’s rates Allergan notes Baa3
|
5/23/2017 | IG | S&P rates Allergan euro notes BBB
|
5/10/2017 | IGLM | Allergan begins one-month tender for up to $2 billion of several notes
|
8/9/2016 | CVIG | S&P upgrades Allergan
|
7/13/2016 | IG | Market Commentary: Japan Bank, Bank of Montreal, International Finance in primary; Anheuser-Busch flat on day
|
4/6/2016 | IG | Market Commentary: KfW, Banque Federative, Swedish Export Credit do deals; Pfizer widens; Newell Rubbermaid firms
|
4/4/2016 | IG | Market Commentary: Primary sees $12 billion of issuance from Target, BMW, others; Pfizer, AT&T tighten modestly
|
11/24/2015 | IG | Market Commentary: Morning Commentary: Allergan tightens; Wells Fargo paper improves; credit spreads ease
|
11/24/2015 | CVIG | Fitch puts Allergan on positive watch
|
11/23/2015 | CVIG | Moody’s reviews Allergan, Actavis, Forest
|
7/28/2015 | BKCVIG | S&P might lift Allergan
|
7/28/2015 | BKCVIG | Fitch affirms Allergan
|
7/27/2015 | BKBWEMIGLM | Teva Pharmaceuticals to obtain up to $27 billion of debt to buy Allergan’s generics business
|
6/17/2015 | BKCVIG | S&P affirms Allergan on Kythera acquisition
|